Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Board/Management Information 2015

Dec 16, 2015

65124_rns_2015-12-16_cfd1298f-4bc6-4f79-bebf-9c7d1054beed.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [175 x 57] intentionally omitted <==

Imugene Limited ACN 009 179 551

17 December 2015

Suite 1, 1233 High Street Armadale VIC 3142

Non-Executive Director Resignation

The Board of Imugene has today received and accepted the resignation of Mr. Otto Buttula as a NonExecutive Director of the company, effective 15 January 2016 after 18 months of service. Mr. Buttula expressed an interest in returning to more hands on executive duties in 2016, necessitating this decision. Mr. Buttula also confirmed that he intends to remain a major shareholder within the Company.

Imugene’s Chairman, Mr. Paul Hopper, expressed his appreciation for Mr Buttula’s contribution not only as a Board member, but also as a strong support of the Company as a major shareholder, and wished him every success with his future activities.

ENDS

For further information please contact:

Imugene:

Leslie Chong, Chief Operating Officer Tel: +61 458 040 433 (Australia), leslie.chong [at]imugene.com

Paul Hopper, Executive Chairman Tel: +61 406 671 515 (Australia), receptogen[at]earthlink.net

Media:

Rudi Michelson, Monsoon Communications Tel: +61 3 9620 3333, rudim[at]monsoon.com.au

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com